ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
1991, 'Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patients.', Drugs, 42, pp. 628 - 639, http://dx.doi.org/10.2165/00003495-199142040-00006
,1990, 'Life-threatening complication of sputum induction.', Lancet, 335, pp. 112 - 113, http://dx.doi.org/10.1016/0140-6736(90)90580-x
,1990, 'Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.', AIDS, 4, pp. 1019 - 1021, http://dx.doi.org/10.1097/00002030-199010000-00012
,1990, 'The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia.', AIDS, 4, pp. 317 - 320, http://dx.doi.org/10.1097/00002030-199004000-00005
,1990, 'The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus.', J Infect, 21, pp. 175 - 181, http://dx.doi.org/10.1016/0163-4453(90)91727-u
,1988, 'Severe exercise hypoxaemia with normal or near normal X-rays: a feature of Pneumocystis carinii infection.', Lancet, 2, pp. 1049 - 1051, http://dx.doi.org/10.1016/s0140-6736(88)90066-9
,1988, 'Reversible bronchoconstriction with nebulised pentamidine.', Lancet, 2, pp. 905, http://dx.doi.org/10.1016/s0140-6736(88)92500-7
,2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017, http://dx.doi.org/10.26190/unsworks/27403
,2008, 'Correlation Between HIV-1 RNA Load in Blood and Seminal Plasma Depending on Antiretroviral Treatment Status, Regimen and Penetration of Semen by Antiretroviral Drugs', in Current HIV Research, Bentham Science Publishing Ltd, Hilversum, Netherlands, pp. 477 - 484, presented at Current HIV Research
,1997, 'Aggressive therapy does not appear to shorten the duration of primary HIV infection (PHI) symptoms.', in Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, 13 November 1997 - 16 November 1997
,1997, 'Therapeutic vaccination with p24-VLP and AZT augments HIV specific CTL activity in asymptomatic HIV-infected individuals.', in Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, 13 November 1997 - 16 November 1997
,1997, 'CD8 activation does not totally normalise in treated primary HIV infection despite undetectable viral load; evidence for ongoing viral replication?', in 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, presented at 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, 11 October 1997 - 15 October 1997
,1997, 'Reversal of CD8 activation in patients with primary HIV infection treated with AZT, 3TC and indinavir.', in 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, presented at 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 29 September 1997 - 01 October 1997
,1997, 'Reversal of lymphocyte RA/RO ratios in patients with primary HIV infection treated with zidovudine, lamivudine and indinavir.', in International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, presented at International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, 25 June 1997 - 29 June 1997
,1997, 'Effect of therapeutic vaccine p24-VLP and AZT on immunological and virological markets in asymptomatic subjects', in 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA, presented at 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA
,1997, 'Fourth Conference on retroviruses an dopportunistic infections', in 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA, presented at 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA
,1996, 'Effects of therapeutic vaccination (p24-VLP) and AZT on immunological and virological markers in asymptomatic subjects', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 137 - 137, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England
,1996, 'Aggressive use of combination antiretroviral by Australian General Practitioners', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 43 - 43, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England
,1996, 'An observational study of antiretroviral treatment in HIV-infected patients attending General Practices in Australia in 1995', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 46 - 46, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England
,1996, 'Clinical and survival benefit of 3TC combination therapy in HIV-1 infection: interim results of the CAESAR study', in Australian Society for HIV Medicine 8th National Conference, Sydney, pp. 103a - 103a, presented at Australian Society for HIV Medicine 8th National Conference, Sydney
,1996, 'Combination therapies in primary HIV infectin', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. OP1.1 - OP1.1, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England
,1996, 'Therapeutic vaccination (p24-VLP) of patients with advanced HIV-1 infection does not alter CD4 decline', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 0P6.5 - 0P6.5, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England
,2019, 'STI incidence and risk factors in HIV-infected adults on antiretrovrial therapy (ART) in the PAART study', Perth, Australia, presented at Joint Australasian Sexual Health and HIV&AIDS Conference, Perth, Australia, 16 September 2019 - 19 September 2019
,2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
,2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', presented at The Australasian HIV&AIDS Conference, Canberra Australia, 06 November 2017 - 08 November 2017
,2019, 'USE OF CONDOMS FOR THE PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS (STIS) AMONG HIV PRE-EXPOSURE PROPHYLAXIS (PREP) USERS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A206 - A206, http://dx.doi.org/10.1136/sextrans-2019-sti.521
,2013, 'Experience of Rapid HIV Testing Increases Its Acceptability to Clinical Staff in Public Sexual Health Clinics in Sydney', in Sexually Transmitted Infections, BMJ Publishing Group, Vol. 89, pp. A345 - A346, http://dx.doi.org/10.1136/sextrans-2013-051184.1081
,2013, 'FIELD PERFORMANCE OF THE ALERE DETERMINE HIV COMBO ASSAY IN A LARGE AUSTRALIAN MULTI-CENTRE STUDY IN A SEXUAL HEALTH CLINIC SETTING', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 89, pp. A55 - A56, http://dx.doi.org/10.1136/sextrans-2013-051184.0170
,2020, Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study, http://dx.doi.org/10.21203/rs.3.rs-106576/v1
,2020, Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study, http://dx.doi.org/10.1101/2020.11.19.20235069
,